1. Home
  2. VTSI vs IFRX Comparison

VTSI vs IFRX Comparison

Compare VTSI & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

N/A

Current Price

$4.20

Market Cap

53.2M

ML Signal

N/A

Logo InflaRx N.V.

IFRX

InflaRx N.V.

N/A

Current Price

$0.95

Market Cap

60.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTSI
IFRX
Founded
1993
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
60.6M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
VTSI
IFRX
Price
$4.20
$0.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$8.50
AVG Volume (30 Days)
26.2K
188.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$16,524,225.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
$1,054.36
P/E Ratio
$45.89
N/A
Revenue Growth
5.57
N/A
52 Week Low
$3.57
$0.71
52 Week High
$7.47
$1.94

Technical Indicators

Market Signals
Indicator
VTSI
IFRX
Relative Strength Index (RSI) 40.47 54.07
Support Level N/A $0.81
Resistance Level $5.15 $1.16
Average True Range (ATR) 0.21 0.06
MACD -0.00 0.01
Stochastic Oscillator 20.38 71.55

Price Performance

Historical Comparison
VTSI
IFRX

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: